In the news

Regardless of experience level, endoscopists reported successful use of the first single-use duodenoscope for endoscopic retrograde cholangiopancreatography, Adam Slivka, MD, PhD, University of Pittsburgh, told Healio Gastroenterology.

Boston Scientific today said it received CE mark approval for its Exalt Model B single-use bronchoscope. The company designed the device for bedside procedures in the intensive care unit, operating room and bronchoscopy suite.

Boston Scientific’s implant led to stroke rates 77% lower than typically expected among older people with atrial fibrillation and high risk scores.

Jeff Mirviss, executive vice president of Boston Scientific’s peripheral business, explains why the specialty’s name doesn’t really reflect the importance of arteries, veins and other “highways” that his business group is addressing.

The clinical trial found a correlation between survival and radiation absorbed by the tumor, giving Boston Scientific data to make the case for using the recently approved device.

The FDA has approved TheraSphere™ Yttrium-90 (Y-90) Glass Microspheres for the treatment of patients with hepatocellular carcinoma.

Boston Scientific aims to acquire Lumenis’ global surgical laser business, through a $1.07 billion deal that will incorporate its systems for ear, nose and throat procedures and its Moses laser treatment for breaking apart kidney stones.

Boston Scientific is making moves to strengthen its line of rhythm management diagnostics with the acquisition of privately held Preventice Solutions, Inc., a company that not only offers remote monitoring for cardiac issues, but also integrates deep learning algorithms and artificial intelligence to generate data used in diagnosis.

Boston Scientific’s Vercise Genus deep brain stimulation (DBS) system portfolio is approved for conditional use in a magnetic resonance imaging (MRI) environment. It features a family of Bluetooth-enabled, rechargeable and non-rechargeable implantable pulse generators capable of powering Cartesia directional leads to offer symptom relief for those suffering from Parkinson’s disease.

The systems are designed to deliver paresthesia-free pain relief in minutes. They are designed with Boston Scientific’s Fast-Acting Sub-perception Therapy (FAST) and have four MRI conditional, Bluetooth-enabled, rechargeable and non-rechargeable implantable pulse generators.

In an effort to solve unemployment issues caused by the coronavirus pandemic and overcome language barriers in the growing Latino and Hispanic population in his community, an immigrant from Costa Rica helped launch an all Spanish-language work shift for Hispanic workers at a medical manufacturing company in Spencer.

Reusable duodenoscopes infected patients in a series of notorious outbreaks. Now there’s a disposable model to be used just once.

SVP Brad Sorenson gives context on how hospitals have recovered during the COVID-19 pandemic and are learning to bifurcate their business to handle both pandemic patients and more typical cases.

Boston Scientific has secured FDA approval for its Ranger paclitaxel-coated balloon, designed to help limit a patient’s systemic exposure to the chemotherapy used to slow the closure of reopened arteries.

“The CHAMPION-AF trial will compare the Watchman FLX device in a head-to-head fashion against best-in-class pharmacological therapy for stroke prevention and evaluate the technology as a first-line therapy for those who can tolerate anticoagulation,” said Ian Meredith, global chief medical officer, Boston Scientific.

How evolving treatment pathways are improving communication and care—both in person and remotely.

HR VP Camille Chang Gilmore explains why Boston Scientific is using data to shine light on healthcare inequality.

Boston Scientific has a plan to tackle systemic racism in healthcare, and to stop the "Black amputation epidemic."

Boston Scientific’s WaveWriter Alpha systems garnered CE Mark approval with indications for managing chronic intractable pain and peripheral nerve stimulation of the trunk for pain management.

This next-generation transcatheter aortic valve implantation (TAVI) technology is a new platform designed with a number of features to improve upon the clinical performance of the original ACURATE neo platform.

Boston Scientific and IBM Research are working together to make chronic pain treatment more individualized—and effective.

“The motive is educating the community,” said Camille Chang Gilmore, global chief diversity officer at Boston Scientific. “We’ve been doing this for 16 years, and we’ve now evolved it to try and figure out how do we bring these resources to people.”

Vercise Genus, a fourth-generation system for deep brain stimulation (DBS), made by Boston Scientific, has received CE marketing and is now commercially available in Europe.

Tune in at the 33-minute mark to hear Boston Scientific’s Brian Dunkin, MD, CMO, Endoscopy, and Dave Pierce, EVP of MedSurg, discuss the EXALT™ Model D single-use duodenoscope in the DeviceTalks Weekly podcast.

Meghan Scanlon hasn’t changed her leadership philosophy much over the years: “It’s to serve and build a high-performing team that can operate smoothly without me, but doesn’t want to.

“Employee resource groups like LEAD provide a huge opportunity for leaders to listen to workers from marginalized groups. Yet, at many companies, they exist in silos…. That's not the case at Boston Scientific.”

Wendy Carruthers, SVP of HR, shares how Boston Scientific is supporting working parents in Boston Globe Media.

In a recent Boston Globe Media column, Donna James—a member of the Boston Scientific board of directors since 2015—draws on her experiences as a Black female board member to call for bold action in pursuit of diverse representation.

"It's because we made all of those changes in the last few years that we were so well-positioned to make the swift, dramatic changes that COVID forced upon us," Chief Information Officer Jodi Eddy told Business Insider.

Boston Scientific has been named one of the top five Fast Company Best Workplaces for Innovators.

Holly Duvernay, the principal employee benefits analyst at Boston Scientific, explains how the company has long been focused on family-support resources.

George Floyd was killed by police in Minneapolis, but his death hit home for Boston Scientific because the company has nearly 9,000 employees in Minnesota.

Boston Scientific has announced winning FDA clearance for its LUX-Dx Insertable Cardiac Monitor (ICM), an implant that can detect hard-to-spot cardiac arrhythmias, such as atrial fibrillation, and help diagnose their origin.

Postponed elective surgeries cost the medical device maker half its business, and George Floyd's death in Minneapolis hit close to home

Desiree Ralls-Morrison expects her team to be business advisers first, but ones armed with expert legal knowledge

Boston Scientific on Monday said CMS approved its application for a transitional pass-through payment category for single-use endoscopes, including its Exalt Model D duodenoscope, under the Medicare hospital outpatient prospective payment system.

Boston Scientific executives today urged U.S. employees to talk, listen and take action against racism and violence, citing Monday’s death of a black man while in police custody in Minneapolis.

Face shields manufactured by Boston Scientific teams at 12 different sites have reached frontline workers in more than 40 states and territories, including two Native American tribes.

In collaboration with Stanford and industry experts, Boston Scientific manufactured and donated the first run of these innovative face shields.

Boston Scientific signed a virtual power purchase agreement (VPPA) for 42 megawatts of solar power and subscribed to a 12.9-MW community solar portfolio.

At Boston Scientific, their priority has been to protect and aid the health and safety of their employees, their physician customers, and their patients.

The Coventor, developed by a team of engineers and medical school faculty at the University of Minnesota, works in a similar way but will cost roughly $1,000 to produce. Boston Scientific plans to begin manufacturing the devices and selling them at cost.

Boston Scientific, with the FDA's quick OK, will start production in Maple Grove in a month or so.

After several months of voting and a live pitch-off at Google’s campus, Boston Scientific announced the winners of its fifth annual Connected Patient Challenge.

“Many people define success in monetary terms; but I think a true definition of success means more than that,” said David Pierce is executive vice president and president, MedSurg, at Boston Scientific.

Following several acquisitions of European companies, US-based medical manufacturer Boston Scientific has issued its first batch of euro-denominated bonds. David Wigan reports.

For the fifth year in a row, Boston Scientific is recognized on Fortune’s list of the World’s Most Admired Companies, ranking in the top 100 overall.